Caroline J. Stone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Caroline J. Stone has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Victoria P. Werth
Corporal Michael J. Crescenz Veterans Affairs Medical Center Philadelphia, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
2 shared publications - Aaron M. Secrest
Department of Dermatology, University of Utah, Salt Lake City, USA
1 shared publication - Aretha On
Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA
1 shared publication - Ashley M. Snyder
Department of Dermatology University of Utah Salt Lake City Utah USA
1 shared publication - Barbara White
Corbus Pharmaceuticals, Norwood, Massachusetts, USA
1 shared publication - Chris Stubben
Cancer Bioinformatics Shared Resource, Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
1 shared publication
Latest Publications
- 15 January 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1827-1836.e4
Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis
- 15 January 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1827-1836.e4
Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis
- Open Access
- 1 July 2025
- Published by SAGE Publications in JRSM Open
- Vol. 16 (7)
Clinically differentiating Behcet's syndrome from Crohn's disease
Lesson: We aim to highlight the diagnostic challenges in differentiating Behcet's syndrome from Crohn's disease, in patients presenting with overlapping clinical features, highlighting the importance of comprehensive clinical evaluation for appropriate management and prognostication.
- 1 July 2025
- Published by SAGE Publications in JRSM Open
- Vol. 16 (7)
Open AccessClinically differentiating Behcet's syndrome from Crohn's disease
Lesson: We aim to highlight the diagnostic challenges in differentiating Behcet's syndrome from Crohn's disease, in patients presenting with overlapping clinical features, highlighting the importance of comprehensive clinical evaluation for appropriate management and prognostication.
- 7 September 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 707-709.e2
Classification of Cutaneous Melanoma and Melanocytic Nevi with MicroRNA Ratios Is Preserved in the Acral Melanoma Subtype
- 7 September 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 707-709.e2
Classification of Cutaneous Melanoma and Melanocytic Nevi with MicroRNA Ratios Is Preserved in the Acral Melanoma Subtype
- Open Access
- 6 September 2024
- Published by Elsevier in JID Innovations
- Vol. 5 (1) , 100311
Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study
- 6 September 2024
- Published by Elsevier in JID Innovations
- Vol. 5 (1) , 100311
Open AccessLong-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study
- Open Access
- 15 August 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (1) , 82-94
Lifestyle, medication use, and age considerations with acne vulgaris: A prospective study
Background: Lifestyle has been associated with acne, but few studies assess how the relationship changes over time. Observational studies often overlook the effects of acne medication use and participant age in relationships with lifestyle‐related factors.Objectives: To describe relationships between lifestyle‐related factors, medication use, and age in adolescent and young adult acne patients and acne‐free controls.Methods: This prospective study recruited 12‐ to 24‐year‐olds with or without acne at baseline. Surveys were electronically administered at enrolment and again 6 weeks later. Analyses were conducted on all participants who had complete baseline data (N = 190) and participants who had complete baseline and follow‐up data (N = 61).Results: Among 190 participants who completed the baseline survey, ages ranged from 12 to 24 years, but acne cases were concentrated in the middle of this range while controls had comparably more participants with ages towards the extremes. Among 61 participants who completed both baseline and follow‐up surveys, no participants indicated worse acne over the 6 weeks, and most acne cases believed their acne improved (n = 25 [69.4%]). Acne cases who used medication daily (N = 24) saw improved emotion‐related quality of life between the two assessments (mean ± standard deviation: 43.4 ± 24.4 to 29.1 ± 23.7; p < 0.001). Among acne cases who used medication daily, average fruit or vegetable consumption increased from 2.4 ± 2.0 to 3.0 ± 2.9 times per day over the preceding 7 days (p = 0.02). Among acne cases who believed their acne improved over the 6 weeks post‐dermatology visit (N = 25), average days of skin picking over the previous 7 days declined between assessments (3.9 ± 2.4 to 2.4 ± 1.9 days; p = 0.003).Conclusions: Medication use and age differences should be considered when designing future studies on acne and lifestyle‐related factors.
- 15 August 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (1) , 82-94
Open AccessLifestyle, medication use, and age considerations with acne vulgaris: A prospective study
Background: Lifestyle has been associated with acne, but few studies assess how the relationship changes over time. Observational studies often overlook the effects of acne medication use and participant age in relationships with lifestyle‐related factors.Objectives: To describe relationships between lifestyle‐related factors, medication use, and age in adolescent and young adult acne patients and acne‐free controls.Methods: This prospective study recruited 12‐ to 24‐year‐olds with or without acne at baseline. Surveys were electronically administered at enrolment and again 6 weeks later. Analyses were conducted on all participants who had complete baseline data (N = 190) and participants who had complete baseline and follow‐up data (N = 61).Results: Among 190 participants who completed the baseline survey, ages ranged from 12 to 24 years, but acne cases were concentrated in the middle of this range while controls had comparably more participants with ages towards the extremes. Among 61 participants who completed both baseline and follow‐up surveys, no participants indicated worse acne over the 6 weeks, and most acne cases believed their acne improved (n = 25 [69.4%]). Acne cases who used medication daily (N = 24) saw improved emotion‐related quality of life between the two assessments (mean ± standard deviation: 43.4 ± 24.4 to 29.1 ± 23.7; p < 0.001). Among acne cases who used medication daily, average fruit or vegetable consumption increased from 2.4 ± 2.0 to 3.0 ± 2.9 times per day over the preceding 7 days (p = 0.02). Among acne cases who believed their acne improved over the 6 weeks post‐dermatology visit (N = 25), average days of skin picking over the previous 7 days declined between assessments (3.9 ± 2.4 to 2.4 ± 1.9 days; p = 0.003).Conclusions: Medication use and age differences should be considered when designing future studies on acne and lifestyle‐related factors.